MET Antibody (LS-B2812)

貨號 Cat. No.
LS-B2812
規格 Size
50 µl
品牌 Brand
LSBio

Description
























































































Antibody Catalog ID: LS-B2812
Antibody Validation: This antibody replaces catalog number LS-C16508. It has been validated for use in the following assays: IHC-P.
Antibody Target: MET
Synonyms: MET Antibody, AUTS9 Antibody, c-met Antibody, hepatocyte growth factor receptor Antibody, HGF receptor Antibody, hgf/sf receptor Antibody, hgfr Antibody, met kinase Antibody, met oncogene Antibody, met proto-oncogene Antibody, oncogene met Antibody, rccp2 Antibody
Family: Protein Kinase
Subfamily: HGF Receptor/MET
Host: MET antibody was produced in Mouse
Antigen Species: MET antibody was raised against Human
Clonality: Monoclonal
Isotype: IgG2a
Antigen Type: Synthetic peptide
Immunogen: MET antibody was raised against synthetic peptide derived from cytoplasmic domain of human c-Met protein
Antibody Specificity: Recognizes c-Met.
Antigen Modification: Cytoplasmic Domain
Purification: Purified
Presentation: PBS, pH 7.4, 1% BSA, 0.1% sodium azide.
Recommended Storage: Long term: -20°C; Short term: +4°C; Avoid freeze-thaw cycles.
Antibody Usage Summary: Immunohistochemistry: LS-B2812 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D2, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2812 was determined to be 10 ug/ml. Positive control: Breast cancer.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (10 µg/ml), Immunohistochemistry - Frozen (IHC-Fr) (1:50) (Optimal dilution to be determined by the researcher)
Size: 50 µl
Concentration: 0.77 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢